Superior Bioavailability of a Novel 1.5% Ashwagandha Formulation (Zenroot™): A Randomized, Double-Blind, Single-Dose, Comparative, Oral Bioavailability Study in Healthy Adults. [PDF]
Ramapalaniappan A +6 more
europepmc +1 more source
System-Level, Molecular and Cellular Mechanisms of Selected Plant Adaptogens-A Review. [PDF]
Such S +3 more
europepmc +1 more source
Comprehensive safety evaluation of <i>Withania somnifera</i> (Ashwagandha): an AI-driven meta-analysis and quantitative structure-activity relationship based toxicity assessment. [PDF]
Ronen Y +5 more
europepmc +1 more source
<i>Rhodiola rosea</i>, <i>Ginkgo biloba</i>, and Ashwagandha as novel antidepressant supplements: converging monoaminergic, neurotrophic, anti-inflammatory, and brain health pathways in depressive disorders. [PDF]
Li X +7 more
europepmc +1 more source
Ashwagandha as an Adaptogenic Herb: A Comprehensive Review of Immunological and Neurological Effects. [PDF]
Jamnekar PP +5 more
europepmc +1 more source
Natural Products with Pharmaceutical Activities. [PDF]
Ooi SL, Pak SC.
europepmc +1 more source
Determination of Withanolides and Withanosides in Ashwagandha Based Products Using HPLC-Drift-Tube-Ion-Mobility Quadrupole Time-of-Flight Mass Spectrometry. [PDF]
Zellner L +5 more
europepmc +1 more source
A New Ashwagandha Formulation (Zenroot™) Alleviates Stress and Anxiety Symptoms While Improving Mood and Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Clinical Study. [PDF]
Mahadevan M +7 more
europepmc +1 more source
Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits. [PDF]
Vittal M, Vinciguerra M.
europepmc +1 more source
Phytochemical and Fungal Bioactive Compounds in the "Brain Health Triad": A Narrative Review on Neurostimulating, Neurotrophic, and Neuroprotective Synergy. [PDF]
Cipriano GL +7 more
europepmc +1 more source

